{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:19:15Z","timestamp":1751948355876,"version":"3.41.2"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["advancesinpediatrics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Pediatrics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.yapd.2024.12.001","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T20:38:39Z","timestamp":1742071119000},"page":"197-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacology in Pediatric Renal Solid Organ Transplantation"],"prefix":"10.1016","volume":"72","author":[{"given":"Christine","family":"Tabulov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"McGee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Fabiola","family":"Marin Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.yapd.2024.12.001_bib1","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa031643","article-title":"Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease","volume":"350","author":"McDonald","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/archdischild-2011-300639","article-title":"Children's experiences of dialysis: a systematic review of qualitative studies","volume":"97","author":"Tjaden","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2024.12.001_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.12659\/AOT.891265","article-title":"Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis","volume":"19","author":"Czy\u017cewski","year":"2014","journal-title":"Ann Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.yapd.2024.12.001_bib4","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1034\/j.1399-3046.2001.005004239.x","article-title":"Pediatric kidney transplantation: historic hallmarks and a personal perspective","volume":"5","author":"Papalois","year":"2001","journal-title":"Pediatr Transplant"},{"year":"2024","series-title":"OPTN\/SRTR 2022 annual data report","key":"10.1016\/j.yapd.2024.12.001_bib6"},{"issue":"7","key":"10.1016\/j.yapd.2024.12.001_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14077","article-title":"Induction and maintenance immunosuppression in pediatric kidney transplantation-Advances and controversies","volume":"25","author":"Balani","year":"2021","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.yapd.2024.12.001_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/B978-0-12-818731-9.00068-9","article-title":"Immunosuppressive drugs","author":"Hussain","year":"2022","journal-title":"Encyclopedia of Infection and Immunity"},{"issue":"9","key":"10.1016\/j.yapd.2024.12.001_bib9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/TP.0b013e318188af15","article-title":"Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids","volume":"86","author":"Offner","year":"2008","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.yapd.2024.12.001_bib10","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1016\/j.transproceed.2011.09.101","article-title":"Clinical description and evolution of renal transplant pediatric patients treated with alemtuzumab","volume":"43","author":"Velez","year":"2011","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00148581-200709050-00005","article-title":"Induction therapy in pediatric renal transplant recipients: an overview","volume":"9","author":"Moudgil","year":"2007","journal-title":"Paediatr Drugs"},{"issue":"7","key":"10.1016\/j.yapd.2024.12.001_bib12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","article-title":"A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients [published correction appears in Transplantation 1999 May 27;67(10):1386]","volume":"67","author":"Brennan","year":"1999","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.yapd.2024.12.001_bib13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.TP.0000158325.12837.A2","article-title":"Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report","volume":"79","author":"Khositseth","year":"2005","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib14","article-title":"Primary pediatric deceased-donor kidney transplant recipients outcomes by immunosuppression induction received in the United States","volume":"25","author":"Riad","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"12","key":"10.1016\/j.yapd.2024.12.001_bib15","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00467-017-3882-2","article-title":"Desensitisation strategies in high-risk children before kidney transplantation","volume":"33","author":"Sharma","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"24","key":"10.1016\/j.yapd.2024.12.001_bib16","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2165\/00003495-200363240-00009","article-title":"Basiliximab: a review of its use as induction therapy in renal transplantation","volume":"63","author":"Chapman","year":"2003","journal-title":"Drugs"},{"year":"2003","series-title":"Simulect\u00ae (basiliximab) [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib17"},{"year":"2024","series-title":"THYMOGLOBULIN\u00ae (anti-thymocyte globulin [rabbit]) [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib18"},{"key":"10.1016\/j.yapd.2024.12.001_bib19","unstructured":"Crowther B. Solid organ transplantation. In: Bernhardt MB, Blackmer AB, Cho HJ, et al, editors. Updates in Therapeutics\u00ae: Pediatric Pharmacy Preparatory Review and e.L. and Recertification Course, KS: American College of Clinical Pharmacy, 2022, p. 643-685."},{"year":"2020","series-title":"CAMPATH\u00ae (alemtuzumab) injection [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib20"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib21","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ekir.2021.01.007","article-title":"Low-dose antithymocyte globulin has No disadvantages to standard higher dose in pediatric kidney transplant recipients: report from the pediatric Nephrology research Consortium","volume":"6","author":"Ashoor","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14713","article-title":"Efficacy and safety of single-dose anti-thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: a retrospective comparative cohort study","volume":"28","author":"Custodio","year":"2024","journal-title":"Pediatr Transplant"},{"issue":"7","key":"10.1016\/j.yapd.2024.12.001_bib23","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/S0041-1345(02)03475-9","article-title":"Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction","volume":"34","author":"Garcia","year":"2002","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1358\/dnp.2003.16.5.829315","article-title":"Molecular actions of calcineurin inhibitors","volume":"16","author":"Hamawy","year":"2003","journal-title":"Drug News Perspect"},{"issue":"6","key":"10.1016\/j.yapd.2024.12.001_bib25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","article-title":"Mode of action of tacrolimus (FK506): molecular and cellular mechanisms","volume":"17","author":"Thomson","year":"1995","journal-title":"Ther Drug Monit"},{"year":"2012","series-title":"Prograf (tacrolimus) capsules\/injection [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib26"},{"year":"2006","series-title":"Sandimmune (cyclosporine capsules, USP) [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib27"},{"year":"2009","series-title":"Neoral (cyclosporine capsules, USP) Modified","key":"10.1016\/j.yapd.2024.12.001_bib28"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib29","first-page":"390","article-title":"Effect of jejunal administration on tacrolimus trough concentrations in a pediatric liver transplant recipient","volume":"27","author":"Aldieri","year":"2022","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.yapd.2024.12.001_bib30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2146\/ajhp130597","article-title":"Medication absorption considerations in patients with postpyloric enteral feeding tubes","volume":"71","author":"McIntyre","year":"2014","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.yapd.2024.12.001_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1399-3046.2005.00402.x","article-title":"Buccal vs. nasogastric tube administration of tacrolimus after pediatric liver transplantation","volume":"10","author":"Goorhuis","year":"2006","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.yapd.2024.12.001_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1034\/j.1399-3046.2002.01052.x","article-title":"Efficacy and pharmacokinetics of tacrolimus oral suspension in pediatric liver transplant recipients","volume":"6","author":"Reding","year":"2002","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.yapd.2024.12.001_bib33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/ajt.13935","article-title":"A steady-state head-to-head pharmacokinetic comparison of all FK-506 (tacrolimus) formulations (ASTCOFF): an open-label, prospective, randomized, two-arm, three-period crossover study","volume":"17","author":"Tremblay","year":"2017","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.ajkd.2017.07.018","article-title":"Results of ASERTAA, a randomized prospective crossover pharmacogenetic study of immediate-release versus extended-release tacrolimus in african American kidney transplant recipients","volume":"71","author":"Trofe-Clark","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00467-018-4117-x","article-title":"The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patients","volume":"34","author":"Schijvens","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/pharmaceutics2030291","article-title":"Tacrolimus pharmacokinetic and pharmacogenomic differences between adults and pediatric solid organ transplant recipients","volume":"2","author":"Marfo","year":"2010","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.yapd.2024.12.001_bib37","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.3390\/pharmaceutics14102154","article-title":"Controversial interactions of tacrolimus with dietary supplements, herbs and food","volume":"14","author":"Miedziaszczyk","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.yapd.2024.12.001_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/tpj.2015.87","article-title":"Genotype-guided tacrolimus dosing in African-American kidney transplant recipients","volume":"17","author":"Sanghavi","year":"2017","journal-title":"Pharmacogenomics J"},{"issue":"10","key":"10.1016\/j.yapd.2024.12.001_bib39","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/ajt.15385","article-title":"Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: a comparison of four ancestry groups","volume":"19","author":"Mohamed","year":"2019","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.yapd.2024.12.001_bib40","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.transproceed.2004.06.026","article-title":"Increased tacrolimus trough levels in association with severe diarrhea, a case report","volume":"36","author":"Asano","year":"2004","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.yapd.2024.12.001_bib41","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1600-6143.2005.00844.x","article-title":"Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea","volume":"5","author":"Lemahieu","year":"2005","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.yapd.2024.12.001_bib42","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1034\/j.1600-6143.2002.21018.x","article-title":"Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients","volume":"2","author":"Maes","year":"2002","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.yapd.2024.12.001_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13733","article-title":"Efficacy and safety of three times daily dosing of tacrolimus in pediatric kidney transplantation patients: a single-center comparative study","volume":"24","author":"Alabdulkarim","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.yapd.2024.12.001_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00003088-199732060-00004","article-title":"Cyclosporin pharmacokinetics in paediatric transplant recipients","volume":"32","author":"Cooney","year":"1997","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003088-200140040-00004","article-title":"Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients","volume":"40","author":"Wallemacq","year":"2001","journal-title":"Clin Pharmacokinet"},{"issue":"6 Suppl 5","key":"10.1016\/j.yapd.2024.12.001_bib46","first-page":"129","article-title":"Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography","volume":"18","author":"Burckart","year":"1986","journal-title":"Transplant Proc"},{"year":"1998","series-title":"Cellcept (mycophenolate mofetil) [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib47"},{"year":"2009","series-title":"Myfortic (mycophenolic acid) [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib48"},{"issue":"7","key":"10.1016\/j.yapd.2024.12.001_bib49","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/S0041-1345(02)03538-8","article-title":"Mechanisms of action of mycophenolate mofetil in preventing chronic rejection","volume":"34","author":"Allison","year":"2002","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.yapd.2024.12.001_bib50","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1399-3046.2005.00386.x","article-title":"Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients","volume":"9","author":"Ettenger","year":"2005","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.yapd.2024.12.001_bib51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.transproceed.2006.10.189","article-title":"Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity?","volume":"39","author":"Arns","year":"2007","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.yapd.2024.12.001_bib52","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s004670100006","article-title":"The use of mycophenolate mofetil suspension in pediatric renal allograft recipients","volume":"16","author":"Bunchman","year":"2001","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib53","article-title":"Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children","volume":"2006","author":"Hartling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.yapd.2024.12.001_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13550","article-title":"Diagnosis and management of diarrhea in solid-organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Angarone","year":"2019","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.yapd.2024.12.001_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.trre.2011.01.001","article-title":"Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation","volume":"25","author":"T\u00f6nshoff","year":"2011","journal-title":"Transplant Rev"},{"year":"2018","series-title":"Imuran (azathioprine) [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib57"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib58","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical pharmacogenetics implementation Consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.yapd.2024.12.001_bib59","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1097\/TP.0000000000002903","article-title":"Immunosuppression and reproductive health after kidney transplantation","volume":"103","author":"Chandra","year":"2019","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14768","article-title":"Adrenal insufficiency in pediatric kidney transplantation recipients","volume":"28","author":"Chae","year":"2024","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib61","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1399-3046.2005.00319.x","article-title":"Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients","volume":"9","author":"Oberholzer","year":"2005","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.yapd.2024.12.001_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14189","article-title":"Steroid avoidance\/withdrawal and maintenance immunosuppression in pediatric kidney transplantation","volume":"26","author":"Kizilbash","year":"2022","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib63","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/FTD.0000000000000439","article-title":"Prednisolone and prednisone pharmacokinetics in pediatric renal transplant recipients-A prospective study","volume":"39","author":"Skauby","year":"2017","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00558515","article-title":"Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets","volume":"37","author":"Al-Habet","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.yapd.2024.12.001_bib65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2016.02.1241","article-title":"Prevention and management of glucocorticoid-induced side effects: a comprehensive review: ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients","volume":"76","author":"Caplan","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.yapd.2024.12.001_bib66","first-page":"285","article-title":"Treatment-associated side effects in patients with steroid-dependent nephrotic syndrome","volume":"17","author":"Croitoru","year":"2022","journal-title":"Maedica (Bucur)"},{"issue":"7","key":"10.1016\/j.yapd.2024.12.001_bib67","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00467-013-2505-9","article-title":"mTOR inhibitors in pediatric kidney transplantation","volume":"29","author":"Pape","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib68","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/ajt.15081","article-title":"Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: results of a randomized trial","volume":"19","author":"T\u00f6nshoff","year":"2019","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.yapd.2024.12.001_bib69","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003088-200544080-00001","article-title":"Sirolimus: the evidence for clinical pharmacokinetic monitoring","volume":"44","author":"Stenton","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.yapd.2024.12.001_bib70","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1034\/j.1399-3046.2002.01070.x","article-title":"Single-dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patients","volume":"6","author":"Van Damme-Lombaerts","year":"2002","journal-title":"Pediatr Transplant"},{"year":"2015","series-title":"RAPAMUNE (sirolimus) [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib71"},{"key":"10.1016\/j.yapd.2024.12.001_bib72","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ahj.2023.02.002","article-title":"The teammate trial: study design and rationale tacrolimus and everolimus against tacrolimus and MMF in pediatric heart transplantation using the major adverse transplant event (MATE) score","volume":"260","author":"Almond","year":"2023","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib74","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/ajt.12712","article-title":"Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors","volume":"14","author":"Kirk","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib75","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/ajt.15611","article-title":"Tailored use of belatacept in adolescent kidney transplantation","volume":"20","author":"Blew","year":"2020","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib76","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/tri.12932","article-title":"Belatacept after kidney transplantation in adolescents: a retrospective study","volume":"30","author":"Lerch","year":"2017","journal-title":"Transpl Int"},{"year":"2011","series-title":"NULOJIX (belatacept) for injection, for intravenous use [package insert]","key":"10.1016\/j.yapd.2024.12.001_bib77"},{"issue":"2","key":"10.1016\/j.yapd.2024.12.001_bib78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00467-014-2813-8","article-title":"Therapeutic drug monitoring in pediatric renal transplantation","volume":"30","author":"Weber","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.yapd.2024.12.001_bib79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/tid.12477","article-title":"Outcomes of Clostridium difficile infection in pediatric solid organ transplant recipients","volume":"18","author":"Pant","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib80","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/TP.0000000000001320","article-title":"Corticosteroid use and growth after pediatric solid organ transplantation: a systematic review and meta-analysis","volume":"101","author":"Tsampalieros","year":"2017","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib81","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1600-6143.2010.03047.x","article-title":"A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study","volume":"10","author":"Grenda","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib82","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00467-017-3637-0","article-title":"Adherence in pediatric kidney transplant recipients: solutions for the system","volume":"33","author":"Steinberg","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1016\/j.yapd.2024.12.001_bib83","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/j.1600-6143.2009.02793.x","article-title":"Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients","volume":"9","author":"Chisholm-Burns","year":"2009","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib84","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1399-3046.2008.01038.x","article-title":"Multidimensional Adherence Classification System: initial development with adolescent transplant recipients","volume":"13","author":"Simons","year":"2009","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib85","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/TP.0000000000004431","article-title":"Kidney-transplanted adolescents-nonadherence and graft outcomes during the transition phase: a nationwide analysis, 2000-2020","volume":"107","author":"Kindem","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.yapd.2024.12.001_bib86","doi-asserted-by":"crossref","first-page":"654","DOI":"10.12659\/AOT.910698","article-title":"Strategies to improve patient engagement in Young kidney transplant recipients: a review","volume":"23","author":"Richards","year":"2018","journal-title":"Ann Transplant"},{"issue":"6","key":"10.1016\/j.yapd.2024.12.001_bib87","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0696","article-title":"Care of pediatric solid organ transplant recipients: an overview for primary care providers","volume":"146","author":"Katz","year":"2020","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.yapd.2024.12.001_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14812","article-title":"Educational needs of the adolescent transplant recipient: a developmental approach to understanding transplant","volume":"28","author":"Molitor","year":"2024","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s10157-021-02143-3","article-title":"Incidence of malignancy after pediatric kidney transplantation: a single-center experience over the past three decades in Japan","volume":"26","author":"Aoki","year":"2022","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"10.1016\/j.yapd.2024.12.001_bib91","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, epstein-barr virus infection, and disease in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.yapd.2024.12.001_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2024.151501","article-title":"Pediatric kidney transplantation: cancer and cancer risk","volume":"44","author":"Order","year":"2024","journal-title":"Semin Nephrol"},{"issue":"3","key":"10.1016\/j.yapd.2024.12.001_bib93","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00467-022-05589-z","article-title":"Cardiovascular disease risk factors and lifestyle modification strategies after pediatric kidney transplantation: what are we dealing with, and what can we target?","volume":"38","author":"Bae","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.yapd.2024.12.001_bib94","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1399-3046.2004.00105.x","article-title":"Risk factors for cardiovascular disease in pediatric renal transplant recipients","volume":"8","author":"Silverstein","year":"2004","journal-title":"Pediatr Transplant"}],"container-title":["Advances in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310124003451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310124003451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:49:23Z","timestamp":1751935763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065310124003451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0065310124003451"],"URL":"https:\/\/doi.org\/10.1016\/j.yapd.2024.12.001","relation":{},"ISSN":["0065-3101"],"issn-type":[{"type":"print","value":"0065-3101"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacology in Pediatric Renal Solid Organ Transplantation","name":"articletitle","label":"Article Title"},{"value":"Advances in Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yapd.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}